SCHEMBL16111196

SCHEMBL16111196

COC(=O)Cc1c(Br)cc[nH]c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.39
EGFR P00533 3/20 0.38
KDM4E B2RXH2 6/20 0.37
KMT2A Q03164 2/20 0.37
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
CHEK1 O14757 1/20 0.36
MAPT P10636 3/20 0.36
GAA P10253 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 1/20 0.36
HSD17B10 Q99714 3/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3174185 0.82 SMN1; SMN2 (0.40) SMN1; SMN2EGFRKDM4EKMT2ACYP4F2
SCHEMBL19475215 0.75 KMT2A (0.49) SMN1; SMN2EGFRKDM4EKMT2ACYP4F2
SCHEMBL11078552 0.72 KDM4E (0.40) SMN1; SMN2EGFRKDM4EKMT2ACYP4F2
SCHEMBL28357703 0.71 CYP4F2 (0.40) SMN1; SMN2EGFRKDM4EKMT2ACYP4F2
SCHEMBL27373221 0.70 KDM4E (0.44) SMN1; SMN2EGFRKDM4EKMT2ACYP4F2
SCHEMBL3171866 0.70 KDM4E (0.45) SMN1; SMN2KDM4EKMT2ACYP4F2CYP4A11
SCHEMBL30755391 0.70 KDM4E (0.44) SMN1; SMN2EGFRKDM4EKMT2ACYP4F2
SCHEMBL23270679 0.69 SMN1; SMN2 (0.50) SMN1; SMN2EGFRKDM4EKMT2AMAPT
SCHEMBL3641015 0.69 KDM4E (0.39) SMN1; SMN2EGFRKDM4EKMT2AMAPT
SCHEMBL14856834 0.68 GPR84 (0.41) SMN1; SMN2KDM4EMAPTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2978425-A2 FACTOR XIa INHIBITORS Merck Sharp & Dohme Corp. (US) 2016-02-03 EP disclosed
WO-2014160592-A2 FACTOR XIa INHIBITORS MERCK SHARP & DOHME CORP. (US) 2014-10-02 WO disclosed